Savara Pharmaceuticals
SVRA
#6474
Rank
C$0.80 B
Marketcap
$4.70
Share price
3.70%
Change (1 day)
-5.49%
Change (1 year)

Earnings for Savara Pharmaceuticals (SVRA)

Earnings in 2024 (TTM): -C$0.11 Billion

According to Savara Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -C$76.47 Million a decrease over its 2022 earnings that were of -C$53.34 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara Pharmaceuticals from 2002 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$0.11 Billion33.29%
2023 -C$76.47 Million43.38%
2022 -C$53.34 Million-11.31%
2021 -C$60.14 Million-13.3%
2020 -C$69.37 Million-36.53%
2019 -C$0.11 Billion13.76%
2018 -C$96.07 Million105.54%
2017 -C$46.74 Million34.11%
2016 -C$34.86 Million-37.43%
2015 -C$55.7 Million38.81%
2014 -C$40.13 Million33.62%
2013 -C$30.03 Million38.49%
2012 -C$21.69 Million24.59%
2011 -C$17.41 Million-36.5%
2010 -C$27.41 Million-3.14%
2009 -C$28.3 Million-23.28%
2008 -C$36.89 Million8.52%
2007 -C$33.99 Million-34.14%
2006 -C$51.61 Million184.43%
2005 -C$18.15 Million90.75%
2004 -C$9.52 Million190.35%
2003 -C$3.28 Million11.64%
2002 -C$2.94 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$25.39 Million-75.88%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$0.35 Billion 224.94%๐Ÿ‡บ๐Ÿ‡ธ USA